Navigation Links
Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
Date:2/6/2013

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP therapy, announced today that Jun Ma , Ph.D., Chief Executive Officer and President, will present at RetailInvestorConferences.com.

DATE:

February 7, 2013

TIME:

12:00 PM EST

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive, online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About Vasomedical, Inc.

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales represent
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lexicon To Present At The BIO CEO & Investor Conference
2. OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
3. Hospira to Present at Upcoming Investor Conferences
4. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
5. Tengion to Present at the BIO CEO & Investor Conference
6. ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12
7. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
8. Regulus to Present at Two Upcoming Investor Conferences
9. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
10. Epizyme to Present at Upcoming Conferences in February
11. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
(Date:6/18/2013)... Internationally acclaimed plastic surgeon, Dr. ... showcasing his unique approach to breast augmentation. Dr. ... surgical method and highlights the results of Dr. ... Dr. Tebbetts compares his breast augmentation method to ... method does not necessitate the use drains, bandages, ...
(Date:6/18/2013)... cancer cells have a much different and more ... The University of Texas at Dallas have found that ... combat lung cancer. , In an article published online ... UT Dallas researchers compared the metabolic characteristics of non-small-cell ... the same patient. , They found that the ...
(Date:6/18/2013)... clinical researchers have launched an innovative clinical trial, ... ability of a patient,s own stem cells to ... disease (PAD). , Led by Vik Kashyap, ... Case Medical Center,s Harrington Heart & Vascular Institute ... University School of Medicine, the clinical trial is ...
(Date:6/18/2013)... venture, using technology developed at Case Western Reserve ... School of Engineering, has made available avatarsvirtual patientsto ... students and others training to evaluate speech-language disorders ... stress on the trainee, because a diagnosis doesn,t ... , Graduate students studying to become speech-language ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network ... if broken, could cut off cancer cell growth at ... at The University of Texas MD Anderson Cancer Center ... a well-known cancer drug target, and MCM7, a protein ... the June issue of Cancer Cell . , ...
Breaking Medicine News(10 mins):Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:SimuCase avatars advance speech-language pathology training 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2
... of Minnesota cancer surgeon and researcher has found a ... the earliest stage of breast cancer choosing to have ... prophylactic mastectomy (CPM) surgery among U.S. women with ductal ... 1998 and 2005, according to Todd Tuttle, M.D., lead ...
... out and destroys tumor cells, researchers say , , FRIDAY, ... virus can target and kill breast cancer stem cells, ... be effective against cancer stem cells, because we have ... cancer cells," Dr. Patrick Lee, a cancer researcher at ...
... Case Timer Solves Widespread ProblemST. LOUIS, April 10 There ... and children are the fastest growing segment. The contact ... growing under those lenses. , , ... fusarium keratitis and acanthamoeba keratitis. These are nasty words ...
... has been promoted to the position of Service Area ... Baron Center, Inc (BCI). Dr. Tau is a ... forensic psychology. Dr. Tau is an expert in assessing ... has been extensively used as a workplace violence and ...
... [Brown University] Nursing homes serving primarily Hispanic ... whose patients were mostly white, according to Brown ... Journal of the American Medical Directors Association ... at the rate of bed sores at nursing ...
... and critical care specialists at Johns Hopkins have begun to ... intensive care unit (ICU) that leads so many patients to ... study reported online April 10 in Critical Care Medicine ... depression six months after hospitalization among very sick ICU patients, ...
Cached Medicine News:Health News:More women with early stage breast cancer choosing double mastectomies 2Health News:Harmless Virus May Be Deadly to Breast Cancer 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 3Health News:Manny Tau, Psy.D. Promoted to Service Area Leader for the Problematic Behaviors Service Area at Baron Center, Inc 2Health News:Hispanics appear to face poorer quality nursing home care 2Health News:In the ICU, use of benzodiazepines, other factors may predict severity of post-stay depression 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: